Treatment of HT29 cells with ALS at 1 and 5 μM led to a 2.3- and 2.6-fold increase in the expression level of E-cadherin, respectively, compared to the control cells (p < 0.01; Figure 9A,B), but treatment of HT29 cells with ALS at 0.1, 1, and 5 μM resulted in a 3.4%, 5.3%, and 27.4% decrease in the expression level of N-cadherin, respectively (Figure 9A,B). This evidence concerns the gene CDH2 and amyotrophic lateral sclerosis.